Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations

This publication has 22 references indexed in Scilit:

• Prospective, Randomized, Double-Blind Study of High-Dose Aprotinin in Pediatric Cardiac Operations
  The Annals of Thoracic Surgery, 1997
• The Efficacy and Cost of Aprotinin in Children Undergoing Reoperative Open Heart Surgery
  Anesthesia & Analgesia, 1996
• A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting
  Circulation, 1995
• Aprotinin in children undergoing correction of congenital heart defects
  The Journal of Thoracic and Cardiovascular Surgery, 1994
• Pharmacokinetics of Aprotinin in Preoperative Cardiac Surgical Patients
  Anesthesiology, 1994
• RETRACTED: Aprotinin in pediatric cardiac operations: Platelet function, blood loss, and use of homologous blood
  The Annals of Thoracic Surgery, 1993
• RETRACTED: Comparison of two aprotinin dosage regimens in pediatric patients having cardiac operations
  The Journal of Thoracic and Cardiovascular Surgery, 1993
• Influence of High-dose Aprotinin Treatment on Blood Loss and Coagulation Patterns in Patients Undergoing Myocardial Revascularization
  Anesthesiology, 1990
• Effects of Aprotinin on Hemostatic Mechanisms during Cardiopulmonary Bypass
  The Annals of Thoracic Surgery, 1987
• EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY
  The Lancet, 1987